Company
MediLink
Drug Conjugates for Global Patients
Also known as MediLink Therapeutics, MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- Operatingas of 2026-09-17
- Headquarters
- Suzhou, China
- Founded
- 2020
- Legal name
- MediLink Therapeutics (Suzhou) Co., Ltd.
- medilinkthera.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Medilink Therapeutics focuses on developing internationally competitive drug conjugates, as well as the latest generation of technologies and products with independent intellectual property rights and better therapeutic windows, to serve the unmet clinical needs. It strives to continuously upgrade technologies, establish diverse technology platforms for drug conjugates, and expand into new disease areas to serve global patients.
Funding snapshot
- Total raised
- $70MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $70M2022-03
Funding rounds
- Series B
- $70M2022-03, Company stated
- Series A
- 2021-02
Loading relationship preview